Orchid Pharma Limited

Stocks

Market Closed - NSE India S.E. Other stock markets 09:19:30 11/06/26 pm AEST			5-day change	1st Jan Change
845.95 ^INR	-0.59%		+1.09%	+11.46%

12:37am	Orchid Pharma Limited Receives Order from Additional Commissioner of Central Tax for Recovery of Erroneously Sanctioned Refund Amount	CI
27/05	Orchid Pharma Limited, Q4 2026 Earnings Call, May 26, 2026

Published on 05/27/2026 at 04:06 am AEST - Modified on 05/27/2026 at 07:12 am AEST

S&P Capital IQ

Presentation Operator Message
Operator (Operator)

Ladies and gentlemen, good day, and welcome to the Orchid Pharma Limited Q4 FY '26 Earnings Con Call hosted by Systematix Shares & Stock Limited.

This article is reserved for subscribers

Unlock the article : SUBSCRIBE!

Already a customer? Log In

12:37am	Orchid Pharma Limited Receives Order from Additional Commissioner of Central Tax for Recovery of Erroneously Sanctioned Refund Amount	CI
27/05	Orchid Pharma Limited, Q4 2026 Earnings Call, May 26, 2026
26/05	Orchid Pharma Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026	CI
13/02	Orchid Pharma Limited, Q3 2026 Earnings Call, Feb 12, 2026
12/02	Orchid Pharma Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 30, 2025	CI
12/02	Orchid Pharma Dec-Qtr Consol Loss 126.1 mln rupees	RE
12/11	Orchid Pharma Limited, Q2 2026 Earnings Call, Nov 11, 2025
11/11	Orchid Pharma Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2025	CI
29/10/25	Orchid Pharma Limited completed the acquisition of all assets of Allecra Therapeutics GmbH and Allecra Therapeutics SAS.	CI
13/08/25	Orchid Pharma Limited, Q1 2026 Earnings Call, Aug 12, 2025
12/08/25	Orchid Pharma Limited Reports Earnings Results for the First Quarter Ended June 30, 2025	CI
07/08/25	CARE Keeps Orchid Pharma's Rating on Rating Watch with Developing Implications	MT
31/07/25	Orchid Pharma to Acquire Allecra Assets, Reclaim Global Rights to Antibiotic; Shares Jump 5%	MT
31/07/25	Orchid Pharma acquired 100% share capital of Weilchensee 1272. V V GmbH	RE
31/07/25	Orchid Pharma to purchase all assets of Allecra Therapeutics GmbH	RE